Avid Bioservices, Inc. (CDMO) Analysts See $-0.14 EPS

March 11, 2018 - By Louis Casey

 Avid Bioservices, Inc. (CDMO) Analysts See $ 0.14 EPS

Analysts expect Avid Bioservices, Inc. (NASDAQ:CDMO) to report $-0.14 EPS on March, 12.They anticipate $0.14 EPS change or 50.00 % from last quarter’s $-0.28 EPS. After having $-0.27 EPS previously, Avid Bioservices, Inc.’s analysts see -48.15 % EPS growth. The stock decreased 3.72% or $0.09 during the last trading session, reaching $2.33. About 527,956 shares traded or 78.80% up from the average. Avid Bioservices, Inc. (NASDAQ:CDMO) has 0.00% since March 11, 2017 and is . It has underperformed by 16.70% the S&P500.

Avid Bioservices, Inc. operates as a contract development and manufacturing organization focusing on the development and cGMP manufacture of biopharmaceutical products derived from mammalian cell culture. The company has market cap of $129.43 million. It provides a range of process development, and cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. It currently has negative earnings. The firm produces monoclonal antibodies and recombinant proteins in batch, fed-batch, and perfusion modes; and provides services, including cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing, and regulatory strategy, submission, and support.

More notable recent Avid Bioservices, Inc. (NASDAQ:CDMO) news were published by: Seekingalpha.com which released: “Can This ‘Avid’ Learn To Fly Again?” on March 08, 2018, also Globenewswire.com with their article: “Avid Bioservices Announces Proposed Offering of Common Stock” published on February 14, 2018, Globenewswire.com published: “Avid Bioservices Selected by Acumen Pharmaceuticals to Lead Process …” on March 01, 2018. More interesting news about Avid Bioservices, Inc. (NASDAQ:CDMO) were released by: Globenewswire.com and their article: “Avid Bioservices Expands Manufacturing Capabilities With Installation and …” published on September 25, 2017 as well as Globenewswire.com‘s news article titled: “Avid Bioservices to Exhibit at 2017 BioProcess International Conference …” with publication date: September 19, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: